RTX-134

N/A

Report date: 2022/12/08 20:00:49

Base Information

Drug NameRTX-134
Drug Alias NameRTX-134
ClassificationCell and gene therapy > Cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionPhenylalanine ammonia-lyase replacements
TargetsPhenylalanine ammonia-lyase
Therapy Area/IndicationsPhenylketonurias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRubius Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRubius Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsPhenylketonurias

Other Information

ATC CodeN/A
Related LinksN/A